- A pharmaceutical company this month tripled the price of an HIV drug that could be used to help treat coronavirus symptoms.
- The company claims that the price increase was decided upon months before the coronavirus pandemic began.
- Visit BGR’s homepage for more stories.
There’s a story making the rounds suggesting that Jaguar Health, a San Francisco-based pharmaceutical company, recently raised the price of one of its drugs by an exorbitant amount after learning it might be used to help treat coronavirus symptoms. As reported by Axios, Jaguar more than tripled the price of Mytesi, an FDA-approved drug that was initially designed to provided relief for HIV patients suffering from non-infectious diarrhea.
While Mytesi typically costs about $668, Jaguar boosted the price to $2,206 earlier this month. In March, Jaguar filed a FORM 8-K with the SEC and disclosed that it asked the FDA for approval to use Mytesi “for the symptomatic relief of diarrhea and other gastrointestinal symptoms in patients with COVID-19 and for patients with COVID-19 who have diarrhea associated with certain antiviral treatments.”
Today’s Top Deals
- Hurry: Amazon’s best-selling face masks are somehow still in stock
- True wireless earbuds with 23,000 5-star ratings are down to $36 at Amazon
- Today’s best deals: Face masks in stock, UV phone sanitizers, crazy Fire HD 8 Tablet deal, rare Bose 700 sale, more
Trending Right Now:
- Flushing the toilet might give you coronavirus
- Where’s my stimulus check? A new reason your money might be delayed
- Best Buy’s big sale is perfect for coronavirus quarantine – here are the 10 best deals
Did a pharma company really triple the price of a drug capable of battling the coronavirus? originally appeared on BGR.com on Thu, 23 Apr 2020 at 15:05:14 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report